To address the new coronavirus surge, the HHS has released new information on the coronavirus booster shots. According to a joint statement from HHS and medical experts, new data suggests that a booster shot will provide maximum protection against the coronavirus for Americans. While new data suggest that the effectiveness of the COVID-19 vaccine is reduced over time, medical experts have now recommended a booster shot in addition to the two vaccine doses of Pfizer and Moderna that are set to protect individuals against severe illness and hospitalization. The statement by HHS and medical experts further states that medical experts anticipate a possible additional booster shot for those individuals who received the Johnson and Johnson vaccine, but medical experts are still conducting research and have not yet released plans for a Johnson and Johnson booster shot.
The Booster Shot
According to NPR, the coronavirus booster shot is set to be available starting the week of September 20th for individuals who have received the Pfizer and Moderna vaccines and need the additional booster shot. Individuals who have received the Pfizer and Moderna vaccines will be eligible for the booster shot eight months after their second dose. According to NPR, results from three new CDC studies show a reduction in protection from coronavirus infection over time, especially against the Delta variant and in nursing homes. The United States Surgeon General cited the “waning immunity against the vaccine and the strength of the Delta variant” in the coming months as a growing concern for health officials, according to NPR.
According to NPR, the shots would be available in the same locations individuals received their first and second vaccine shots of the Pfizer and Moderna vaccines. According to the data by NPR, 90% of Americans lived within five miles of one of the almost 80,000 vaccine sites.
According to NPR, the U.S. hopes to provide booster shots to 100 million Americans.
Approval of the Pfizer Vaccine
Additionally, according to NPR, the FDA has approved the Pfizer vaccine, a widely anticipated decision that replaces the emergency use authorization granted by the FDA last December. According to NPR, this is the first coronavirus vaccine to be approved by the FDA. According to the Kaiser Family Foundation June poll, 31% of unvaccinated individuals said they would be more likely to get the vaccine if it was approved by the FDA.
According to the Kaiser Family Foundation, Figure 7 shows that most individuals don’t know that the coronavirus vaccine is available under FDA emergency use authorization.
Vaccine Authorization Not Yet Available for Children Under 12
However, the authorization does not extend vaccine FDA approval to children under age 12, and there are still ongoing trials and data to be submitted to make a decision on whether to approve vaccines for children under age 12.
Future Moderna Vaccine Approval
As is customary with the approval process, the Pfizer vaccine got a brand name, Comirnaty. As well, the Moderna vaccine is under review and is expected to receive FDA approval in the near future.
American Exchange: How Can We Help?
American Exchange can help you address your billing backlogs. As a practice, you may be short-staffed and unable to process your billing at the rate your practice is seeing patients. This is where American Exchange can help. We have the background, knowledge, and certified coders who can accurately and efficiently process your billing. With the accuracy and efficiency of our American Academy of Professional Coders, American Exchange has a clean claims rate of 90%. Along with our ability to address your billing backlogs and provide a clean claims process, we can also handle your accounts receivables from the processing of payment to collections with ease and accuracy. American Exchange also offers reports for clients to get a clearer picture of your financial performance. With the help of American Exchange, you won’t have to worry about the stress of processing claims, billings, and collections, as you can leave those processes to us.